CEPI – Novavax, COVID-19 Vaccine Funding Agreement Post author:GHIAA Admin Post published:January 10, 2023 Post category: Continue ReadingCEPI – Novavax, COVID-19 Vaccine Funding Agreement
CEPI – VBI, COVID-19 Vaccine Development Funding Agreement Post author:GHIAA Admin Post published:December 13, 2022 Post category: Continue ReadingCEPI – VBI, COVID-19 Vaccine Development Funding Agreement
CEPI – VBI, COVID-19 Vaccine Development Funding Agreement Post author:GHIAA Admin Post published:December 12, 2022 Post category: Continue ReadingCEPI – VBI, COVID-19 Vaccine Development Funding Agreement
CEPI – Novavax, COVID-19 Vaccine Funding Agreement Post author:GHIAA Admin Post published:September 16, 2022 Post category: Continue ReadingCEPI – Novavax, COVID-19 Vaccine Funding Agreement
Merck – MPP, Molnupiravir License Agreement Post author:GHIAA Admin Post published:November 22, 2021 Post category: Continue ReadingMerck – MPP, Molnupiravir License Agreement
US Army Contracting Command (via ATI) – Regeneron, COVID-19 Antibodies Large-Scale Manufacturing Agreement Post author:GHIAA Admin Post published:September 1, 2021 Post category: Continue ReadingUS Army Contracting Command (via ATI) – Regeneron, COVID-19 Antibodies Large-Scale Manufacturing Agreement
US Army Contracting Command (via ATI) – Regeneron, COVID-19 Antibodies Large-Scale Manufacturing Agreement Post author:GHIAA Admin Post published:August 19, 2021 Post category: Continue ReadingUS Army Contracting Command (via ATI) – Regeneron, COVID-19 Antibodies Large-Scale Manufacturing Agreement
CEPI CfP3i Template Funding Agreement Post author:GHIAA Editor Post published:May 22, 2020 Post category: Continue ReadingCEPI CfP3i Template Funding Agreement